Titan Pharmaceuticals Provides Overview of Upcoming Clinical Study of Probuphine Following Clear Guidance From the FDA April 30, 2014
Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2013 Financial Results March 26, 2014
Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for Probuphine Clinical Study March 3, 2014
Titan Pharmaceuticals Receives Official Minutes From FDA Meeting on Probuphine New Drug Application December 23, 2013
Titan Pharmaceuticals Announces $5 Million Equity Investment and Restructuring of Probuphine Partnership November 13, 2013
Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2013 Financial Results November 8, 2013
Titan Pharmaceuticals Announces Confirmation of Meeting With FDA Regarding Probuphine September 26, 2013
Titan Pharmaceuticals Announces Submission of FDA Meeting Request Regarding Probuphine September 4, 2013
